CO MPJE common mistakes
CO MPJE · Understand the traps and how to avoid them.
Applying federal DEA schedules and rules to a controlled substance prescription without checking the Minnesota-specific scheduling or additional requirements (e.g., assuming a drug is Schedule IV federally but Minnesota places it in a more restrictive schedule, or missing Minnesota's specific rules for Schedule II faxed prescriptions).
Candidates study federal law in isolation and treat Minnesota as a mere add-on, so they default to federal answers when the state rule is stricter or different. The exam often tests the state-specific nuance.
What to do instead
For every controlled substance question, explicitly ask: 'What does federal law require?' and 'What does Minnesota law require?' Then apply the stricter rule. Memorize Minnesota's unique scheduling (e.g., Minnesota places anabolic steroids in Schedule III, unlike federal Schedule III? Actually federal anabolic steroids are Schedule III; check Minnesota-specific additions like tramadol? Minnesota schedules tramadol? Not sure. Better to say: Review Minnesota's controlled substance schedules in Minn. Stat. § 152.02 and note any substances that Minnesota schedules differently from federal, and always check both.
Dispensing a prescription without verifying that all required elements are present on the face of the prescription (prescriber name, DEA number when required, patient name and address, drug name, strength, dosage form, quantity, directions, date, refills, and prescriber signature) and assuming that missing elements can be added later without prescriber authorization.
Candidates focus on the clinical appropriateness of the drug and overlook the legal document requirements. They also confuse what a pharmacist may add or clarify versus what requires a new prescription.
What to do instead
Create a checklist of required prescription elements under Minnesota law (Minn. Stat. § 151.01 et seq. and Minn. R. 6800) and federal law for controlled substances. For each element, note whether a pharmacist may add it, clarify it with the prescriber, or must obtain a new prescription. Practice by reviewing sample prescriptions and identifying deficiencies.
Counseling patients only on the mechanics of taking the medication (dose, frequency) and omitting legally required counseling points such as proper storage, disposal, potential interactions, and what to do if a dose is missed, or failing to document that counseling was offered or refused.
Candidates treat counseling as a soft skill and underestimate the specific content required by Minnesota law and the documentation obligation. They also forget that counseling must be offered to every patient receiving a new prescription.
What to do instead
Memorize the Minnesota counseling requirements (Minn. Stat. § 151.212 and rules) and the elements of appropriate counseling. Use a structured counseling framework (e.g., prime questions) and practice documenting counseling offers and refusals in the patient record. Review the Board of Pharmacy's guidance on counseling.
Assuming that a pharmacist may delegate any task to a pharmacy technician or intern without considering the specific supervision ratios, tasks that must be performed by a licensed pharmacist, and the level of supervision required (direct vs. indirect) for each task.
Candidates generalize from their own work experience, where delegation may be routine, and fail to check the Minnesota rules that define technician duties, ratios, and supervision levels.
What to do instead
Study Minn. R. 6800.9950 and related statutes on pharmacy technician registration, duties, and supervision. Create a table of tasks (e.g., receiving verbal prescriptions, compounding, final verification) and note who may perform them and under what supervision. Pay attention to ratio limits in different practice settings.
Responding to a disciplinary scenario by focusing only on the pharmacist's clinical error and ignoring the legal obligation to report the error or the practitioner to the Board, or missing the mandatory reporting requirements for impaired practitioners or fraudulent prescriptions.
Candidates view discipline as a matter of personal ethics rather than a structured regulatory process with mandatory reporting duties. They are unfamiliar with the Minnesota reporting statutes and the grounds for discipline.
What to do instead
Review Minn. Stat. § 214.17 (reporting obligations) and the Board of Pharmacy's disciplinary grounds (Minn. Stat. § 151.29). Memorize who must report, what must be reported, and the timeframes. Practice scenario questions where a pharmacist witnesses misconduct and must decide whether and how to report.
Confusing the requirements for licensure by examination, licensure by reciprocity (score transfer), and registration of pharmacy technicians, including the differing fees, timelines, and continuing education requirements.
Candidates lump all credentialing pathways together and rely on general knowledge rather than the specific Minnesota application processes and deadlines.
What to do instead
Create a comparison chart of the pathways: examination (NAPLEX/MPJE), reciprocity (license transfer), and technician registration. List the required documents, fees, fingerprinting, and CE hours for each. Note the renewal cycles and CE requirements for pharmacists and technicians separately.
Dispensing a controlled substance without ensuring that the prescription is issued for a legitimate medical purpose in the usual course of professional practice, and failing to recognize red flags of diversion (e.g., cash payment, long distances, early refills) or to document the resolution of those red flags.
Candidates focus on the technical validity of the prescription (e.g., correct DEA number) and neglect the corresponding responsibility doctrine, which requires the pharmacist to resolve red flags before dispensing.
What to do instead
Study the corresponding responsibility doctrine (21 CFR § 1306.04) and Minnesota cases or Board guidance on red flags. Practice by reviewing prescriptions with red flags and writing a documentation note that explains how each red flag was resolved. Remember that documentation is key.
Failing to maintain required records for the statutory retention period (e.g., prescription records, controlled substance inventories, counseling documentation) or storing them in a format that is not readily retrievable or not compliant with Minnesota's electronic recordkeeping rules.
Candidates underestimate the operational side of recordkeeping and assume that if a record exists somewhere, it satisfies the law. They also overlook the specific retention periods for different record types.
What to do instead
Memorize the retention periods: Minnesota requires prescription records for at least 5 years (Minn. Stat. § 151.19), and controlled substance records for 2 years under federal law (21 CFR § 1304.04). Create a table of record types, retention periods, and storage formats (e.g., readily retrievable, electronic). Review the Board's recordkeeping rules.
Ignoring the specific labeling requirements for prescription medications, including auxiliary labels, beyond-use dates, and the required information on the prescription label (pharmacy name, address, prescription number, date, patient name, directions, prescriber, and cautions).
Candidates assume that labeling is a minor detail and focus on the drug itself. They also forget that Minnesota has specific labeling rules that may exceed federal requirements.
What to do instead
Study Minn. Stat. § 151.21 and Minn. R. 6800.3600 on labeling. List all required label elements and auxiliary labels for common high-risk medications. Practice by reviewing sample labels and identifying missing elements. Pay attention to the requirement to include the purpose of the medication if requested by the patient.
Assuming that a pharmacist may compound any preparation without checking whether the compounding is permitted under Minnesota law, whether it requires a specific license or equipment, or whether it is considered manufacturing requiring an FDA-registered facility.
Candidates are familiar with compounding from practice but are unaware of the legal boundaries between compounding and manufacturing, and the specific Minnesota rules on sterile and non-sterile compounding.
What to do instead
Review Minn. Stat. § 151.01 and Minn. R. 6800.4000 et seq. on compounding, including the distinction between compounding and manufacturing. Study USP <795> and <797> standards as adopted by Minnesota. Create a flowchart for determining whether a preparation is compounding or manufacturing, and note the licensing and facility requirements for sterile compounding.